02.08.2017 Secondary Announcement-p.m.

IPOBoutique.Com rates secondary offerings to hit the tape with a ‘BUY’, ‘NEUTRAL’ or ‘AVOID’ rating. Senior Managing Partner Scott Sweet maintains a track record for all secondary’s he’s issued with a ‘BUY’ rating.

Company: Sierra Oncology
Symbol: SRRA
Price: Last trade $1.42
Description: Re-offer $1.35
Trade Date: 2/9
Shares: 18.5 million
Underwriter(s)Jefferies
Rating=Subscription Needed